BRIEF published on 06/18/2026 at 09:35, 2 months 13 days ago AATec Medical dévoilera les données de l'ATL-105 lors de sa conférence de 2026. ATL-105 Données Précliniques Bronchectasie Traitement Multimodal Essai De Phase 1/2
BRIEF published on 06/18/2026 at 09:35, 2 months 13 days ago AATec Medical to Unveil ATL-105 Data at 2026 Conference Preclinical Data ATL-105 Phase 1/2 Trial Bronchiectasis Multimodal Treatment
PRESS RELEASE published on 06/18/2026 at 09:30, 2 months 13 days ago AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026 AATec to present preclinical data on lead candidate ATL-105 at World Bronchiectasis Conference 2026, demonstrating multimodal effects for non-CF bronchiectasis treatment Respiratory Diseases Preclinical Data ATL-105 Bronchiectasis AATec
BRIEF published on 07/15/2025 at 09:05, 1 year 1 month ago AATec Medical et Northway Biotech forment un partenariat pour le développement de la production d'ATL-105 Partenariat ATL-105 Fabrication De Produits Biologiques Maladies Pulmonaires Thérapie Respiratoire
BRIEF published on 07/15/2025 at 09:05, 1 year 1 month ago AATec Medical and Northway Biotech Form Partnership for ATL-105 Production Development Partnership ATL-105 Biologics Manufacturing Lung Diseases Respiratory Therapy
PRESS RELEASE published on 07/15/2025 at 09:00, 1 year 1 month ago AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases AATec Medical and Northway Biotech announce partnership to develop industrial production process for ATL-105 targeting lung diseases Partnership AATec Medical ATL-105 Lung Diseases Northway Biotech
BRIEF published on 04/15/2025 at 11:09, 1 year 4 months ago AATec Medical Secures EUR 4 Million for Respiratory Drug Development Biotechnology Funding Clinical Trials Drug Development Respiratory Diseases
BRIEF published on 04/15/2025 at 11:09, 1 year 4 months ago AATec Medical obtient 4 millions d'euros pour le développement de médicaments respiratoires Biotechnologie Financement Essais Cliniques Développement De Médicaments Maladies Respiratoires
PRESS RELEASE published on 04/15/2025 at 11:04, 1 year 4 months ago AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development AATec Medical secures EUR 4 million funding to advance lead respiratory drug candidate, ATL-105, for clinical development to treat non-CF bronchiectasis by 2026 Clinical Development AATec Medical Non-CF Bronchiectasis EUR 4 Million Respiratory Drug Candidate
BRIEF published on 09/18/2024 at 10:05, 1 year 11 months ago AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
Published on 08/31/2026 at 13:30, 1 hour 8 minutes ago Nextech3D.ai Delivers 101% Revenue Growth in Fiscal Q1 2027 as AI-Powered Event Platform Accelerates
Published on 08/31/2026 at 13:30, 1 hour 8 minutes ago Condor Receives Environmental Permit (DIA) for Drilling at Flagship Pucamayo Project
Published on 08/31/2026 at 13:00, 1 hour 38 minutes ago CoTec Provides Update on Commercial Deployment of Multi-Gravity Separator Technology
Published on 08/31/2026 at 13:00, 1 hour 38 minutes ago ATHA Energy Provides Board of Directors Update
Published on 08/31/2026 at 12:45, 1 hour 53 minutes ago Northern Dynasty Minerals Reports Change to Board of Directors
Published on 08/31/2026 at 12:47, 1 hour 51 minutes ago hep global successfully develops two solar projects with battery storage systems west of Munich
Published on 08/31/2026 at 12:45, 1 hour 53 minutes ago TCL Powers the Tides of Annihilation Experience at Gamescom 2026 with Advanced Display Technology
Published on 08/31/2026 at 10:35, 4 hours 3 minutes ago Deufol SE publishes two key reports: the half-year report 2026 with the operational figures for the first half of the year and the second voluntary sustainability report for the 2025 financial year.
Published on 08/31/2026 at 12:00, 2 hours 38 minutes ago Capital increase through exercise of subscription rights
Published on 08/31/2026 at 12:00, 2 hours 38 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 08/31/2026 at 07:00, 7 hours 38 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Published on 08/31/2026 at 07:00, 7 hours 38 minutes ago Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
